Percutaneous Coronary Intervention Guidance Devices Market to Grow at a CAGR of 6.1% from 2022 to 2031: TMR Study

PRESS RELEASE
Published March 10, 2023

WILMINGTON, DE / ACCESSWIRE / March 10, 2023 / Extensive adoption of guide catheters in percutaneous coronary intervention has created significant revenue opportunities for medical device companies in the global Percutaneous Coronary Intervention Guidance Devices Market. Increase in R&D of coronary guidewires and catheters is likely to improve patient outcomes and broaden the market outlook. The market value is projected to exceed US$ 23.5 Bn by the end of 2031.

https://storage.googleapis.com/accesswire/media/743107/percutaneous-coronary-intervention-guidance-devices-market.jpg

Rise in prevalence of coronary artery disease, especially in the elderly, is fueling technological advancements in guidewires and catheters. New catheter designs and novel stenting technologies are being utilized in PCI, leading to better surgical outcomes in patients with chronic symptomatic coronary artery disease. For instance, utilization of bioresorbable scaffolds is expected to increase in percutaneous coronary interventions.

Medtech companies in the percutaneous coronary intervention guidance devices industry strive to develop and commercialize vascular closure devices that can reduce complications in PCI procedures especially among patients with a significant risk profile. These initiatives are likely to open up new opportunities for market players.

Request for a Sample PDF Report with Latest Industry Insights (Use Corporate Mail Id for Quick Response):
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85387

Key Findings of Study

  • Substantial Demand for Guide Catheters: There has been a rapid increase in usage of catheter-based procedures to treat coronary heart diseases in patients worldwide. Extensive utilization of guidewires in percutaneous coronary intervention has boosted the Percutaneous Coronary Intervention Guidance Devices Market size. Adoption of advanced guide catheters in modern angioplasty procedures has propelled revenue growth for companies in the overall coronary intervention guidance devices market. The guide catheter segment held the leading market share in 2021.
  • Design and Technology Advancements in PCI to Offer Attractive Opportunities: Advancement in technologies in catheterization are benefitting patients who undergo percutaneous coronary interventions. Usage of artificial intelligence (AI) has proved helpful to predict complications in percutaneous coronary interventions, for instance, application of current AI methods to obtain three-dimensional coronary anatomy reconstruction, which enable interventional cardiologists to plan PCI strategies accordingly. Increase in adoption of these technologies is poised to accelerate the Percutaneous Coronary Intervention Guidance Devices Market development. Need for minimally invasive procedures to treat ischemic heart disease is expected to fuel R&D activities in PCI guidance devices.

Key Drivers

  • Rapidly increasing healthcare spending to manage cardiovascular disease in developing countries is a key trend expected to bolster the Percutaneous Coronary Intervention Guidance Devices Market
  • Surge in prevalence of cardiovascular disease and high health burden of coronary artery disease are likely to drive product demand in the market
  • Significant utilization of new imaging techniques such as those used in coronary angiogram and adoption of advanced catheter navigation strategies in procedures used to treat coronary artery disease have opened new avenues for market growth

Buy this Premium Research Report (170 Pages PDF with Insights, Charts, Tables, Figures): https://www.transparencymarketresearch.com/checkout.php?rep_id=85387<>

Regional Growth Dynamics

  • North America held leading share in the Percutaneous Coronary Intervention Guidance Devices Market in 2021. The region is projected to account for significant market share during the forecast period. Presence of advanced healthcare infrastructure and rapid adoption of advanced technologies for minimally invasive cardiovascular procedures are expected to propel the market. Presence of several large medical device manufacturers in North America and favorable reimbursement framework for patients undergoing percutaneous coronary interventions are likely to fuel market expansion in the next few years.
  • The market in Asia Pacific is anticipated to witness considerable revenue growth in the next few years. Surge in demand for advanced medical technology to manage cardiovascular disease in the elderly population and awareness about effectiveness of PCI procedures to treat coronary artery diseases are likely to create lucrative opportunities for companies in the regional market.

Competition Landscape

Market research found that mergers and acquisitions, strategic collaborations, and product launches are key competitive strategies adopted by leading players in the Percutaneous Coronary Intervention Guidance Devices Market to consolidate their positions.

Prominent companies in the market are

  • Boston Scientific Corporation,
  • Johnson and Johnson Services,
  • Abbott,
  • Terumo Corporation,
  • Biosensors International Group,
  • Medtronic,
  • B. Braun SE,
  • Cordis,
  • Conmed Corporation,
  • Emirates Health Services,
  • Meril Life Sciences, and Koninklijke Philips N.V.

As Per Your Requirement, You Can Customize This Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85387

Percutaneous Coronary Intervention Guidance Devices Market Segmentation

Product

  • Percutaneous Sheath Introducers
  • Guide Catheters
  • Guidewires
  • Others

Indication

  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Others

End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services has pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

SOURCE: Transparency Market Research Inc.



View source version on accesswire.com:
https://www.accesswire.com/743107/Percutaneous-Coronary-Intervention-Guidance-Devices-Market-to-Grow-at-a-CAGR-of-61-from-2022-to-2031-TMR-Study

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.